ANNAPOLIS, Md. — Governor Wes Moore and AstraZeneca today announced plans to invest $2 billion to expand AstraZeneca’s manufacturing footprint in Maryland, representing the largest private capital investment in the state in the last decade.
The investment includes a significant expansion of AstraZeneca’s flagship biologics manufacturing facility in Frederick and construction of a new state-of-the-art clinical manufacturing facility in Gaithersburg—supporting 2,600 jobs.
“AstraZeneca’s significant investment and expansion in Maryland underscores our state’s global leadership in life sciences and biomanufacturing,” said Gov. Moore. “This landmark investment strengthens the U.S. medicine supply chain and accelerates the development of life-saving therapies, while creating hundreds of good-paying jobs for Marylanders. We are proud to partner with AstraZeneca to grow our economy and build new pathways to work, wages, and wealth for all.”…